Ellen G. J. Hulskotte

Pharmacokinetics and safety of letermovir, a novel anti‐human cytomegalovirus drug, in patients with renal impairment

H. Stobernack, H. Zimmermann, A. Halabi, 2017, British journal of clinical pharmacology.